This article is
- freely available
Animal Models of Dengue Virus Infection
Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, 1 Barker Hall, Berkeley, CA 94720, USA
* Author to whom correspondence should be addressed.
Received: 2 November 2011; in revised form: 18 December 2011 / Accepted: 22 December 2011 / Published: 9 January 2012
Abstract: The development of animal models of dengue virus (DENV) infection and disease has been challenging, as epidemic DENV does not naturally infect non-human species. Non-human primates (NHPs) can sustain viral replication in relevant cell types and develop a robust immune response, but they do not develop overt disease. In contrast, certain immunodeficient mouse models infected with mouse-adapted DENV strains show signs of severe disease similar to the ‘vascular-leak’ syndrome seen in severe dengue in humans. Humanized mouse models can sustain DENV replication and show some signs of disease, but further development is needed to validate the immune response. Classically, immunocompetent mice infected with DENV do not manifest disease or else develop paralysis when inoculated intracranially; however, a new model using high doses of DENV has recently been shown to develop hemorrhagic signs after infection. Overall, each model has its advantages and disadvantages and is differentially suited for studies of dengue pathogenesis and immunopathogenesis and/or pre-clinical testing of antiviral drugs and vaccines.
Keywords: animal models; dengue virus; pathogenesis; immunopathogenesis; antiviral drugs; vaccines
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
Cite This Article
MDPI and ACS Style
Zompi, S.; Harris, E. Animal Models of Dengue Virus Infection. Viruses 2012, 4, 62-82.
Zompi S, Harris E. Animal Models of Dengue Virus Infection. Viruses. 2012; 4(1):62-82.
Zompi, Simona; Harris, Eva. 2012. "Animal Models of Dengue Virus Infection." Viruses 4, no. 1: 62-82.